KNSA (Kiniksa Pharmaceuticals) Forward P/E Multiple

Corporate company logo of Kiniksa Pharmaceuticals Ltd (KNSA)

Kiniksa Pharmaceuticals focuses on developing drugs for the treatment of rare immune and cardiovascular pathologies, avoiding the mass market. The GURU.Markets terminal displays the company's forward P/E ratio, where the value 47.50 indicates the valuation status. The business implements targeted methods to combat autoinflammation, creating a closed ecosystem for patients with pericarditis under strict FDA control.

Projected Price to Earnings: Kiniksa (KNSA) for 07/04/2022 - 11/16/2026

Analytical breakdowns for Kiniksa Pharmaceuticals

Summary company analytics:kiniksa.com
Product sample of Kiniksa Pharmaceuticals

Investors are verifying the asset's long-term sustainability by comparing current market capitalization with expected net income to assess the premium paid for future growth. By analyzing the forward P/E ratio of Kiniksa Pharmaceuticals (KNSA), one can determine the extent to which the market is willing to award a premium for its closed ecosystem for treating rare pathologies, where integration with clinics guarantees a stable cash flow and mitigates patient attrition risks.

Competitors of Kiniksa Pharmaceuticals (KNSA)

Projected Price to Earnings ARGX (Argenx)|BNTX (BioNTech Group) - Future Price to Earnings Multiple|Forward P/E Multiple ABVX (Abivax SA)|Market Cap to Projected Earnings admabiologics.com (ADMA)|PTGX - Future Price to Earnings|Immunovant Inc (IMVT) - Projected Price to Earnings|Grifols Biemat (GRFS) - Future Price to Earnings|Projected Price to Earnings Adaptive Biotechnologies|Projected Price to Earnings CLDX|Forward P/E Multiple auriniapharma.com|Future Price to Earnings BioCryst Pharmaceuticals Inc (BCRX)|Vera Therapeutics - Price to Future Earnings Ratio|Forward P/E Multiple DNTH (dianthustx.com)|Pharvaris Pharma (PHVS) - Projected Price to Earnings Ratio|AbCellera Biologics - Forward P/E Multiple|tourmalinebio.com - Market Cap to Future Earnings Ratio|Precigen (PGEN) - Future Price to Earnings|Pharming Group - Future Price to Earnings Multiple|Future Price to Earnings Nektar Therapeutics Inc|UPB (Upstream Pharma) - Market Cap to Future Earnings Ratio|Forward P/E Multiple ZBIO|Forward P/E Multiple immunome.com (IMNM)|Forward P/E Multiple GOSS (gossamerbio.com)|Market Cap to Projected Earnings KalVista Pharma (KALV)|SEPN - Future Price to Earnings|Market Cap to Projected Earnings Pieris Pharmaceuticals PVLA|SVRA (Savara Inc.) - Projected Price to Earnings|Price to Expected Earnings Ratio RIGL (Rigel Pharmaceuticals)|ANAB (AnaptysBio) - Forward P/E Multiple|ATXS (Astria Therapeutics, Inc.) - Market Cap to Future Earnings Ratio|Future Price to Earnings engene.com (ENGN)|RAPT (RAPT Therapeutics, Inc.) - Future Price to Earnings Multiple|Aerovate Therapeutics - Projected Price to Earnings|Future Price to Earnings Multiple ACRS|Kyverna Therapeutics, Inc - Forward P/E Multiple|Price to Expected Earnings Ratio TLSA|CABA: Forward P/E Multiple|Projected Price to Earnings Ventyx Bio|Future Price to Earnings Theratechnologies, Inc.|Projected Price to Earnings Ratio Avalo Therapeutics AVTX|Forward P/E Multiple ELDN|AGEN (Agenus, Inc.) - Future Price to Earnings Multiple|Future Price to Earnings Climb Bio, Inc. CLYM|Zura Bio Limited (ZURA) - Projected Price to Earnings Ratio|ATYR: Projected Price to Earnings|adagene.com (ADAG) - Projected Price to Earnings|Ikena Oncology (IMA) - Future Price to Earnings|Projected Price to Earnings Shattuck Labs, Inc.|Future Price to Earnings equilliumbio.com|Projected Price to Earnings connectbiopharm.com (CNTB)|Forward P/E Multiple IMUX|Market Cap to Projected Earnings Atara Bio|Future Price to Earnings InflaRx N.V. IFRX|X4 Pharmaceuticals - Future Price to Earnings|ACET: Projected Price to Earnings|Future Price to Earnings Multiple CELU (celularity.com)|INMB: Forward P/E Multiple|BRNS: Market Cap to Future Earnings Ratio|KZR (Kezar Life Sciences, Inc.) - Forward P/E Multiple|SAB Biotherapeutics Inc. (SABS) - Market Cap to Projected Earnings|Forward P/E Multiple AKTX|Future Price to Earnings ENLV (Enlivex Therapeutics Ltd)|Future Price to Earnings Q32 Bio Inc. QTTB|GOVX - Projected Price to Earnings|EDSA - Future Price to Earnings|Projected Price to Earnings Ratio iBio|CARM: Forward P/E Multiple|Price to Expected Earnings Ratio XTLB (XTL Biopharmaceuticals, Ltd.)|Future Price to Earnings boltbio.com|Forward P/E Multiple HCW Biologics|Forward P/E Multiple APVO|AIM - Projected Price to Earnings Ratio|Forward P/E Multiple ADTX (Aditxt Inc.)|Market Cap to Projected Earnings GRI Bio, Inc. (GRI)|XRTX - Future Price to Earnings|reshapelifesciences.com (HIND) - Projected Price to Earnings|REVB: Forward P/E Multiple|Indaptus Therapeutics, Inc. - Future Price to Earnings Multiple|Future Price to Earnings Scinai|Projected Price to Earnings Ratio CalciMedica, Inc. CALI|Future Price to Earnings Affimed NV (AFMD)|Forward P/E Multiple Allakos Inc (ALLK)|Future Price to Earnings hookipapharma.com HOOK|Forward P/E Multiple IGM Biosciences, Inc. IGMS|iTeos Pharma - Forward P/E Multiple|OCEA - Forward P/E Multiple|TCBP: Forward P/E Multiple|Third Harmonic Bio - Future Price to Earnings Multiple